Stacey L. Hart
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stacey L. Hart has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- David M. Latini
Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA
4 shared publications - Heather Honoré Goltz
Social Work Program, University of Houston-Downtown, Houston, TX, USA
4 shared publications - Marc A. Kowalkouski
Michael E. DeBakey VA Medical Center (MEDVAMC 152)
4 shared publications - Janet Waimin Lee
Duke University School of Medicine
3 shared publications - Julia R. Berian
Department of Surgery, University of Wisconsin-Madison, Madison, WI
3 shared publications - David Curtis Mohr
Center for Behavioral Intervention Technologies, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
2 shared publications
Latest Publications
- 1 January 2013
- Published by Springer Nature
- p. 314-317
Cancer, Prostate
- 1 January 2013
- Published by Springer Nature
- p. 1547-1548
Prostate-Specific Antigen (PSA)
- 1 January 2013
- Published by Springer Nature
- p. 1545-1546
Prostate
- 13 May 2012
- Published by Springer Nature in Journal of Clinical Psychology in Medical Settings
- Vol. 20 (1) , 123-132
Impact of Depression and Anxiety on the Quality of Life of Constipated Patients
Constipation negatively affects quality of life (QOL), however, the specific mechanisms through which this relationship occurs are unclear. The present study examined anxiety and depression as potential mediators of the relationship between constipation severity and QOL in a sample of 142 constipated patients. Results indicated that depression symptom severity mediated the relationship between constipation severity and mental health-related QOL. For patients meeting diagnostic criteria for Major Depressive Disorder, indirect effects were observed in the relationship between constipation severity and both physical and mental health-related QOL. Anxiety did not contribute to this model. Treating depression may be useful in improving QOL in severely constipated patients, which highlights the importance of psychological screening and treatment referrals in primary care settings.
- 13 May 2012
- Published by Springer Nature in Journal of Clinical Psychology in Medical Settings
- Vol. 20 (1) , 123-132
Impact of Depression and Anxiety on the Quality of Life of Constipated Patients
Constipation negatively affects quality of life (QOL), however, the specific mechanisms through which this relationship occurs are unclear. The present study examined anxiety and depression as potential mediators of the relationship between constipation severity and QOL in a sample of 142 constipated patients. Results indicated that depression symptom severity mediated the relationship between constipation severity and mental health-related QOL. For patients meeting diagnostic criteria for Major Depressive Disorder, indirect effects were observed in the relationship between constipation severity and both physical and mental health-related QOL. Anxiety did not contribute to this model. Treating depression may be useful in improving QOL in severely constipated patients, which highlights the importance of psychological screening and treatment referrals in primary care settings.
- 9 December 2011
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 27 (4) , 459-466
A randomized controlled trial of anorectal biofeedback for constipation
The purposes of this study were: (1) to examine the efficacy of anorectal biofeedback (AB) for constipation compared to a biofeedback control (BC) treatment and (2) to examine the extent to which self-reported childhood sexual/physical abuse predicted biofeedback outcome. Twenty-one patients with pelvic floor dyssynergia were randomized to either (1) an AB arm, where patients learned to isolate the anal sphincter using an electromyography probe, or (2) a BC arm that controlled for the nonspecific effects of biofeedback, where patients learned to relax trapezius or temporalis muscles with EMG feedback. Both treatments were delivered by registered nurses for six sessions. Prior to randomization and post-treatment, patients completed the validated Constipation Severity Instrument and two measures of quality of life (QOL), the Irritable Bowel Syndrome-QOL, and the SF-36. Generalized estimating equations examined the within-group and between-group differences over time. Pre- and post-treatment data were obtained for six AB and nine BC patients. AB patients' overall constipation severity scores decreased by 35.5% (vs. 15.3%), and their obstructive defecation symptom scores decreased by 37.9% (vs. 19.7%) compared to BC. A similar pattern was shown on the IBS-QOL. On the SF-36 Mental Health Composite (MCS), AB scores improved 28.0% compared to BC scores, which worsened 12.7%. Those without (vs. with) a childhood sexual/physical abuse history showed improvement on the MCS post-biofeedback. While our sample was statistically underpowered, AB produced clinical improvements in constipation severity and QOL.
- 9 December 2011
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 27 (4) , 459-466
A randomized controlled trial of anorectal biofeedback for constipation
The purposes of this study were: (1) to examine the efficacy of anorectal biofeedback (AB) for constipation compared to a biofeedback control (BC) treatment and (2) to examine the extent to which self-reported childhood sexual/physical abuse predicted biofeedback outcome. Twenty-one patients with pelvic floor dyssynergia were randomized to either (1) an AB arm, where patients learned to isolate the anal sphincter using an electromyography probe, or (2) a BC arm that controlled for the nonspecific effects of biofeedback, where patients learned to relax trapezius or temporalis muscles with EMG feedback. Both treatments were delivered by registered nurses for six sessions. Prior to randomization and post-treatment, patients completed the validated Constipation Severity Instrument and two measures of quality of life (QOL), the Irritable Bowel Syndrome-QOL, and the SF-36. Generalized estimating equations examined the within-group and between-group differences over time. Pre- and post-treatment data were obtained for six AB and nine BC patients. AB patients' overall constipation severity scores decreased by 35.5% (vs. 15.3%), and their obstructive defecation symptom scores decreased by 37.9% (vs. 19.7%) compared to BC. A similar pattern was shown on the IBS-QOL. On the SF-36 Mental Health Composite (MCS), AB scores improved 28.0% compared to BC scores, which worsened 12.7%. Those without (vs. with) a childhood sexual/physical abuse history showed improvement on the MCS post-biofeedback. While our sample was statistically underpowered, AB produced clinical improvements in constipation severity and QOL.
- Open Access
- 17 November 2011
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 35 (1) , 183-192
Development and assessment of the constipation‐related disability scale
Aliment Pharmacol Ther 2012; 35: 183–192Summary: Background Chronic constipation is associated with impaired quality of life and physical discomfort. Although inability to engage in day‐to‐day activities has been significantly associated with psychological distress, limited research has examined this relationship in constipated samples.Aim To develop and validate the Constipation‐Related Disability Scale (CRDS), which assesses the extent of disability caused by constipation.Methods A total of 240 constipated participants and 103 healthy controls completed the CRDS. Reliability was measured with Cronbach’s coefficient alpha and test–retest reliability was assessed with intraclass correlation coefficients. Convergent, divergent and predictive validity were assessed.Results Component and factor analyses were used to derive two factors: Work/Leisure Activities and Activities of Daily Living, as well as a total CRDS score. Good reliability was found, with alphas ≥0.87 and intraclass correlation coefficients ≥0.85. All scales were negatively correlated with the physical health subscales of the SF‐36 (P < 0.001) and were not significantly correlated with the Epworth Sleepiness Scale and Social Desirability Scale, providing support for convergent and divergent validity, respectively. Evidence of predictive validity was supported by associations between the total CRDS with number of physician visits per year (P < 0.01), missed work in the last year (odds ratio [OR] = 1.11, 95% confidence interval [CI] = 1.06–1.19, P < 0.001) and ER visits in the last year (OR = 1.08, 95% CI = 1.00–1.16, P < 0.05).Conclusions The Constipation‐Related Disability Scale is the first instrument that assesses the impact of constipation on daily activities. There is evidence of strong reliability and validity of the instrument.
- 17 November 2011
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 35 (1) , 183-192
Open AccessDevelopment and assessment of the constipation‐related disability scale
Aliment Pharmacol Ther 2012; 35: 183–192Summary: Background Chronic constipation is associated with impaired quality of life and physical discomfort. Although inability to engage in day‐to‐day activities has been significantly associated with psychological distress, limited research has examined this relationship in constipated samples.Aim To develop and validate the Constipation‐Related Disability Scale (CRDS), which assesses the extent of disability caused by constipation.Methods A total of 240 constipated participants and 103 healthy controls completed the CRDS. Reliability was measured with Cronbach’s coefficient alpha and test–retest reliability was assessed with intraclass correlation coefficients. Convergent, divergent and predictive validity were assessed.Results Component and factor analyses were used to derive two factors: Work/Leisure Activities and Activities of Daily Living, as well as a total CRDS score. Good reliability was found, with alphas ≥0.87 and intraclass correlation coefficients ≥0.85. All scales were negatively correlated with the physical health subscales of the SF‐36 (P < 0.001) and were not significantly correlated with the Epworth Sleepiness Scale and Social Desirability Scale, providing support for convergent and divergent validity, respectively. Evidence of predictive validity was supported by associations between the total CRDS with number of physician visits per year (P < 0.01), missed work in the last year (odds ratio [OR] = 1.11, 95% confidence interval [CI] = 1.06–1.19, P < 0.001) and ER visits in the last year (OR = 1.08, 95% CI = 1.00–1.16, P < 0.05).Conclusions The Constipation‐Related Disability Scale is the first instrument that assesses the impact of constipation on daily activities. There is evidence of strong reliability and validity of the instrument.
- 20 July 2011
- Published by Wiley in Psycho-Oncology
- Vol. 21 (12) , 1324-1330
Moderators of cancer‐related distress and worry after a pancreatic cancer genetic counseling and screening intervention
Objectives: Although the hereditary breast and ovarian cancer literature has demonstrated short‐term gains in psychological adjustment following genetic counseling, there has been limited research examining long‐term outcomes and moderators. Moreover, there has been minimal research into the psychological effects of this intervention in populations at high risk for pancreatic cancer. This study examines the long‐term effects of pancreatic cancer screening and genetic counseling on cancer‐related distress and cancer worry in a high‐risk population at 1‐year follow‐up. Additionally, this study explores potential moderators of the effectiveness of this intervention.Methods: One hundred twenty‐nine participants with familial pancreatic cancer or with the BRCA2 gene mutation completed a baseline questionnaire prior to their first pancreatic cancer screening and genetic counseling session. Participants also completed questionnaires at 3‐ and 12‐month follow‐up.Results: Cancer‐related intrusive thoughts decreased significantly over time, whereas cancer‐related worry decreased at 3 months and showed a small but significant increase at 1 year. Age and baseline distress exhibited moderator effects. Younger individuals showed a significant decrease in cancer‐related intrusive thoughts, cancer‐related avoidant thoughts, and cancer worry. Additionally, individuals with greater baseline distress showed a significant decrease in cancer‐related intrusive thoughts over time.Conclusions: Analysis of the long‐term effects of pancreatic cancer screening and genetic testing reveal psychological gains that are maintained at 1‐year follow‐up. This intervention is particularly effective for younger participants and individuals with greater baseline distress. Copyright © 2011 John Wiley & Sons, Ltd.
- 20 July 2011
- Published by Wiley in Psycho-Oncology
- Vol. 21 (12) , 1324-1330
Moderators of cancer‐related distress and worry after a pancreatic cancer genetic counseling and screening intervention
Objectives: Although the hereditary breast and ovarian cancer literature has demonstrated short‐term gains in psychological adjustment following genetic counseling, there has been limited research examining long‐term outcomes and moderators. Moreover, there has been minimal research into the psychological effects of this intervention in populations at high risk for pancreatic cancer. This study examines the long‐term effects of pancreatic cancer screening and genetic counseling on cancer‐related distress and cancer worry in a high‐risk population at 1‐year follow‐up. Additionally, this study explores potential moderators of the effectiveness of this intervention.Methods: One hundred twenty‐nine participants with familial pancreatic cancer or with the BRCA2 gene mutation completed a baseline questionnaire prior to their first pancreatic cancer screening and genetic counseling session. Participants also completed questionnaires at 3‐ and 12‐month follow‐up.Results: Cancer‐related intrusive thoughts decreased significantly over time, whereas cancer‐related worry decreased at 3 months and showed a small but significant increase at 1 year. Age and baseline distress exhibited moderator effects. Younger individuals showed a significant decrease in cancer‐related intrusive thoughts, cancer‐related avoidant thoughts, and cancer worry. Additionally, individuals with greater baseline distress showed a significant decrease in cancer‐related intrusive thoughts over time.Conclusions: Analysis of the long‐term effects of pancreatic cancer screening and genetic testing reveal psychological gains that are maintained at 1‐year follow‐up. This intervention is particularly effective for younger participants and individuals with greater baseline distress. Copyright © 2011 John Wiley & Sons, Ltd.
- 1 January 2011
- Published by American Psychological Association (APA) in Rehabilitation Psychology
- Vol. 56 (2) , 117-122
Improvements in partner support predict sexual satisfaction among individuals with multiple sclerosis.
Sexual dysfunction and low sexual satisfaction are common among individuals with multiple sclerosis (MS); however, little is known about factors that influence sexual satisfaction within this population. As such, the purpose of this study was to investigate the extent to which changes in negative and positive partner support predict sexual satisfaction levels over time in individuals with MS. Eighty-one individuals with MS completed measures of sexual dysfunction, sexual satisfaction, partner social support, and depression. Data from baseline and posttreatment follow-up were obtained from a larger randomized clinical trial of telephone-administered psychotherapy for depression in a population with MS. Multiple regression analyses were conducted with change in overall sexual satisfaction from baseline to posttreatment as the outcome variable. After controlling for age, gender, sexual dysfunction, years diagnosed with MS, and depression severity, those with increased positive partner support reported significant improvement in sexual satisfaction over time (β = .50, p < .001), as did individuals with decreased negative partner support (β = .36, p < .01). Results provide evidence that both positive and negative partner support have a distinctive role in the outcome of sexual satisfaction for individuals with MS. Understanding the unique role of positive and negative forms of partner support on sexual satisfaction will help lead to future interventions to improve sexual satisfaction among couples.
- 1 January 2011
- Published by American Psychological Association (APA) in Rehabilitation Psychology
- Vol. 56 (2) , 117-122
Improvements in partner support predict sexual satisfaction among individuals with multiple sclerosis.
Sexual dysfunction and low sexual satisfaction are common among individuals with multiple sclerosis (MS); however, little is known about factors that influence sexual satisfaction within this population. As such, the purpose of this study was to investigate the extent to which changes in negative and positive partner support predict sexual satisfaction levels over time in individuals with MS. Eighty-one individuals with MS completed measures of sexual dysfunction, sexual satisfaction, partner social support, and depression. Data from baseline and posttreatment follow-up were obtained from a larger randomized clinical trial of telephone-administered psychotherapy for depression in a population with MS. Multiple regression analyses were conducted with change in overall sexual satisfaction from baseline to posttreatment as the outcome variable. After controlling for age, gender, sexual dysfunction, years diagnosed with MS, and depression severity, those with increased positive partner support reported significant improvement in sexual satisfaction over time (β = .50, p < .001), as did individuals with decreased negative partner support (β = .36, p < .01). Results provide evidence that both positive and negative partner support have a distinctive role in the outcome of sexual satisfaction for individuals with MS. Understanding the unique role of positive and negative forms of partner support on sexual satisfaction will help lead to future interventions to improve sexual satisfaction among couples.
- 1 August 2009
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 52 (8) , 1434-1442
A Valid and Reliable Measure of Constipation-Related Quality of Life
Few existing measures assess constipation-specific quality of life. This study sought to develop a valid and reliable quality-of-life measure for constipation. First, we created a preliminary instrument that assessed quality-of-life domains affected by constipation: body image, eating, mood, and relationships with others. We conducted focus groups both with patients with constipation seeking treatment and the health care providers who treat them. Next, a 59-item questionnaire was given to 240 subjects with constipation (83% female) and 103 healthy volunteers (63% female). Test-retest reliability and discriminant, convergent, and divergent validity were assessed. Exploratory factor analysis revealed four domains: Social Impairment (five items), Distress (six items), Eating Habits (three items), and Bathroom Attitudes (four items). Internal consistency and test-retest reliability for all subscales was high (Cronbach's alpha = 0.89; intraclass correlation coefficient = 0.87). All domains discriminated well between subjects with constipation and healthy volunteers (P < 0.001). Convergent validity was excellent: all subscales correlated highly with the Irritable Bowel Syndrome Quality of Life Scale total score (P < 0.001) and the Medical Outcomes Study Short Form-36 physical component and mental component summary scores (P < 0.001). Scores from our Constipation-Related Quality of Life measure were not significantly correlated with the Social Desirability Scale, demonstrating divergent validity. Our findings support the reliability and validity of the Constipation-Related Quality of Life measure. Future validation of the Constipation-Related Quality of Life measure for assessing changes in quality of life in response to treatments for constipation is needed.
- 1 August 2009
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 52 (8) , 1434-1442
A Valid and Reliable Measure of Constipation-Related Quality of Life
Few existing measures assess constipation-specific quality of life. This study sought to develop a valid and reliable quality-of-life measure for constipation. First, we created a preliminary instrument that assessed quality-of-life domains affected by constipation: body image, eating, mood, and relationships with others. We conducted focus groups both with patients with constipation seeking treatment and the health care providers who treat them. Next, a 59-item questionnaire was given to 240 subjects with constipation (83% female) and 103 healthy volunteers (63% female). Test-retest reliability and discriminant, convergent, and divergent validity were assessed. Exploratory factor analysis revealed four domains: Social Impairment (five items), Distress (six items), Eating Habits (three items), and Bathroom Attitudes (four items). Internal consistency and test-retest reliability for all subscales was high (Cronbach's alpha = 0.89; intraclass correlation coefficient = 0.87). All domains discriminated well between subjects with constipation and healthy volunteers (P < 0.001). Convergent validity was excellent: all subscales correlated highly with the Irritable Bowel Syndrome Quality of Life Scale total score (P < 0.001) and the Medical Outcomes Study Short Form-36 physical component and mental component summary scores (P < 0.001). Scores from our Constipation-Related Quality of Life measure were not significantly correlated with the Social Desirability Scale, demonstrating divergent validity. Our findings support the reliability and validity of the Constipation-Related Quality of Life measure. Future validation of the Constipation-Related Quality of Life measure for assessing changes in quality of life in response to treatments for constipation is needed.